MedTech Acquisition Corporation Registered Shs Aktie
WKN DE: A3EP5W / ISIN: US89680M1018
15.05.2024 14:22:48
|
TriSalus Life Sciences, Inc. Q1 Loss Climbs
(RTTNews) - TriSalus Life Sciences, Inc. (TLSI) revealed Loss for its first quarter that increased from the same period last year
The company's bottom line came in at -$14.020 million, or -$0.60 per share. This compares with -$9.227 million, or -$0.57 per share, in last year's first quarter.
The company's revenue for the quarter rose 116.4% to $6.457 million from $2.984 million last year.
TriSalus Life Sciences, Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$14.020 Mln. vs. -$9.227 Mln. last year. -EPS (Q1): -$0.60 vs. -$0.57 last year. -Revenue (Q1): $6.457 Mln vs. $2.984 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MedTech Acquisition Corporation Registered Shsmehr Nachrichten
11.08.25 |
Ausblick: MedTech Acquisition legt Quartalsergebnis vor (finanzen.net) | |
14.05.25 |
Ausblick: MedTech Acquisition präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu MedTech Acquisition Corporation Registered Shsmehr Analysen
Aktien in diesem Artikel
MedTech Acquisition Corporation Registered Shs | 4,65 | -0,43% |
|